Free Trial

Oxford Nanopore Technologies (LON:ONT) Stock Price Down 10.2% - Should You Sell?

Oxford Nanopore Technologies logo with Medical background

Shares of Oxford Nanopore Technologies plc (LON:ONT - Get Free Report) traded down 10.2% during mid-day trading on Monday . The stock traded as low as GBX 127 ($1.59) and last traded at GBX 128.50 ($1.61). 3,354,197 shares were traded during mid-day trading, an increase of 54% from the average session volume of 2,182,529 shares. The stock had previously closed at GBX 143.10 ($1.79).

Analysts Set New Price Targets

Several research analysts have weighed in on the company. JPMorgan Chase & Co. reaffirmed an "overweight" rating on shares of Oxford Nanopore Technologies in a research note on Friday, December 6th. Berenberg Bank reiterated a "buy" rating and issued a GBX 282 ($3.54) price objective on shares of Oxford Nanopore Technologies in a report on Tuesday, September 3rd. Finally, Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a GBX 190 ($2.38) target price on shares of Oxford Nanopore Technologies in a report on Wednesday, September 4th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus target price of GBX 235.50 ($2.95).

Read Our Latest Analysis on Oxford Nanopore Technologies

Oxford Nanopore Technologies Stock Down 10.2 %

The firm has a 50 day moving average of GBX 142.50 and a two-hundred day moving average of GBX 129.78. The firm has a market capitalization of £1.21 billion, a price-to-earnings ratio of -642.50 and a beta of 0.80. The company has a quick ratio of 6.01, a current ratio of 4.45 and a debt-to-equity ratio of 8.07.

Insider Activity at Oxford Nanopore Technologies

In other news, insider Gurdial (Gordon) Sanghera sold 1,993,571 shares of the business's stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of GBX 142 ($1.78), for a total value of £2,830,870.82 ($3,548,791.30). Insiders purchased 310 shares of company stock worth $45,010 over the last three months. Company insiders own 32.62% of the company's stock.

Oxford Nanopore Technologies Company Profile

(Get Free Report)

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Oxford Nanopore Technologies Right Now?

Before you consider Oxford Nanopore Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford Nanopore Technologies wasn't on the list.

While Oxford Nanopore Technologies currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines